+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Comments

Loading...

Otsuka Holdings

OTSKFOTCPK

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$39.48

-9.77-24.76%

At close: Mar 8, 2:18 AM EDT

$29.71

-9.77-24.76%

After Hours: Mar 8, 2:18 AM EDT

15 minutes delayed

Otsuka Holdings (OTSKF) Forecast

News

Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for Otsuka Holdings (OTC:OTSKF) Stock

Otsuka Holdings Stock (OTC: OTSKF)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, April 16, 2024

IGC Pharma Says Cannabinoid-Based Drug Candidate Provides Fast Relief With Fewer Side Effects For Alzheimer's-Associated Agitation
Vandana Singh

Wednesday, March 20, 2024

Alzheimer's-Focused Small Cap Firm IGC Pharma Releases Data, Candidate Reduces Agitation Compared To Placebo
Vandana Singh

Tuesday, September 05, 2023

Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More
Lara Goldstein

Thursday, August 31, 2023

Mindset Pharma's $60M Acquisition, Otsuka's Leap Into Next-Gen Psychiatry Solutions
Lara Goldstein

Thursday, August 24, 2023

Regulatory Setback For Medtronic's High Blood Pressure Device - FDA Backed Japanese Firms' Similar Device For Uncontrolled Hypertension
Vandana Singh

Wednesday, August 23, 2023

Individuals With Uncontrolled Hypertension - FDA Adcomm Panel Just Supported Japanese MedTech's Blood Pressure Treatment Device
Vandana Singh

Thursday, May 11, 2023

Japan's Otsuka Pharma-Lundbeck Partnered Depression Drug Gets FDA Approval For Alzheimer's Agitation
Vandana Singh

Tuesday, July 19, 2022

Psychedelics Management Updates: Two Top Companies Appoint New CEOs, Here's What We Know
Lara Goldstein

Friday, July 01, 2022

The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact
Vandana Singh

Thursday, March 24, 2022

Five Companies Developing Second Generation P...
Benzinga Newsdesk

Monday, October 11, 2021

1906 New Highs Leverages Cannabis 3.0 to Give Consumers Safer and More Effective Aids for Sleep, Anxiety, Mood, and Focus
Mark Gilman - Sponsored

Wednesday, January 17, 2018

5 Weed Stocks To Watch In 2018
Benzinga

Friday, February 17, 2017

Exclusive: Following Up Akebia, Johnson & Johnson's Research And License Agreement
Benzinga

Wednesday, September 24, 2014

US Stock Futures Up Ahead Of New Home Sales Report
Benzinga
FDA Accepts Otsuka and Lundbeck's Filing for Review of Brexpiprazole for Treatment of Schizophrenia and as Adjunctive Therapy for Treatment of Major Depression
Benzinga

Wednesday, October 02, 2013

Astex Pharmaceuticals Urges Shareholders to Tender Shares into Otsuka Offer
Benzinga

Wednesday, September 04, 2013

Benzinga's M&A Chatter for Wednesday September 4, 2013
Benzinga

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved